At 6 months of age, TgF344-AD rats have reduced basal synaptic transmission, increased Aβ oligomers, hyperphosphorylated tau and activated microglia and astrocytes25,55 as well as reduced tyrosine hydroxylase positive axons in the hippocampus29,57. This evidence concerns the gene MAPT and Alzheimer disease.